GlassScriptPhysician profile
Daniel Walter Zumofen
NPI 1255672945
$32,136.53
in general payments reported to CMS, 2019-2025
19 companies · $1,611 in 2025
The $1,611 reported for 2025 was more than what a typical Neurological Surgery provider received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $117 · 2020: $1,376 · 2021: $1,578 · 2022: $14K · 2023: $8,960 · 2024: $4,477 · 2025: $1,611.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $7,575 · Travel and Lodging: $4,712 · Food and Beverage: $2,740 · Education: $20.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $7,575.00 |
| Travel and Lodging | $4,712.34 |
| Food and Beverage | $2,740.15 |
| Education | $20.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Rapid Medical LTD | $23,072.80 | 2022-2025 | Comaneci 17, Tigertriever 17 Revascularization Device |
| Medtronic, INC. | $2,166.16 | 2021-2024 | Pipeline, Linq II |
| Imperative Care, INC | $1,679.85 | 2022-2024 | Zoom 88-T Large Distal Platform, Zoom Reperfusion Catheter |
| Medtronic USA, INC. | $1,278.23 | 2020 | |
| Livanova USA, INC. | $1,053.81 | 2021 | |
| Csl Behring | $495.15 | 2023-2025 | Kcentra, Haegarda |
| Balt USA, LLC | $469.31 | 2022-2023 | |
| Contego Medical, INC | $322.18 | 2025 | |
| Astrazeneca Pharmaceuticals LP | $280.45 | 2021-2023 | |
| Phenox INC. | $269.93 | 2021-2022 | |
| Globus Medical, INC. | $231.33 | 2023-2025 | Excelsiusgps Robotic Navigation System, Reline, Assure |
| Penumbra, INC. | $214.25 | 2020-2023 | Benchmark, Red 72 |
| Microvention, INC. | $161.35 | 2022-2023 | Sofia 6f-131cm Str, Stent, Web Aneurysm Embolization System |
| Irras USA, INC. | $147.03 | 2024 | |
| Depuy Synthes Sales INC. | $116.77 | 2019 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $85.28 | 2024-2025 | Adherus Autospray Dural Sealant, Vsp System, Vsp Cranial |
| Ethicon US, LLC | $36.22 | 2024 | Evarrest, Vistaseal, Surgiflo Hemostatic Matrix |
| Gt Medical Technologies, INC | $29.68 | 2022 | |
| Innovation Technologies INC | $26.75 | 2024 | Irrisept |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Zumofen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.